English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Drug Channels Institute
Patient Daily
| Feb 3, 2026
Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
Trending
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+
Pharmaceuticals
Patient Daily
| Jan 30, 2026
Senate gridlock delays decision on rare disease priority review voucher program
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
+
Pharmaceuticals
Patient Daily
| Feb 2, 2026
Clinical trial landscape shifts globally as China increases role in innovation
